KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non-Current Assets (2020 - 2026)

AbCellera Biologics filings provide 7 years of Non-Current Assets readings, the most recent being $642.5 million for Q1 2026.

  • Quarterly Non-Current Assets rose 10.93% to $642.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $642.5 million through Mar 2026, up 10.93% year-over-year, with the annual reading at $628.7 million for FY2025, 3.21% up from the prior year.
  • Non-Current Assets hit $642.5 million in Q1 2026 for AbCellera Biologics, up from $628.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $660.9 million in Q3 2025 and bottomed at $417.9 million in Q1 2022.
  • Average Non-Current Assets over 5 years is $587.2 million, with a median of $609.2 million recorded in 2024.
  • The largest annual shift saw Non-Current Assets soared 89.49% in 2022 before it decreased 10.77% in 2025.
  • AbCellera Biologics' Non-Current Assets stood at $515.4 million in 2022, then grew by 19.54% to $616.1 million in 2023, then dropped by 1.12% to $609.2 million in 2024, then grew by 3.21% to $628.7 million in 2025, then rose by 2.19% to $642.5 million in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Non-Current Assets are $642.5 million (Q1 2026), $628.7 million (Q4 2025), and $660.9 million (Q3 2025).